Human placental growth hormone is increased in maternal serum at 20 weeks of gestation in pregnancies with large-for-gestational-age babies

Growth Factors. 2016 Dec;34(5-6):203-209. doi: 10.1080/08977194.2016.1273223. Epub 2017 Jan 25.

Abstract

To investigate the relationship between maternal serum concentrations of placental growth hormone (GH-V), insulin-like growth factor (IGF)-1 and 2, IGF binding proteins (IGFBP)-1 and 3 and birth weight in appropriate-for-gestational-age (AGA), large-for-gestational-age (LGA) and small-for-gestational-age (SGA) cases in a nested case-control study. Maternal serum samples were selected from the Screening for Pregnancy Endpoints (SCOPE) biobank in Auckland, New Zealand. Serum hormone concentrations were determined by ELISA. We found that maternal serum GH-V concentrations at 20 weeks of gestation in LGA pregnancies were significantly higher than in AGA and SGA pregnancies. Maternal GH-V concentrations were positively correlated to birth weights and customized birth weight centiles, while IGFBP-1 concentrations were inversely related to birth weights and customized birth weight centiles. Our findings suggest that maternal serum GH-V and IGFBP-1 concentrations at 20 weeks' gestation are associated with fetal growth.

Keywords: Placental growth hormone; birth weight; large-for-gestational-age; pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Birth Weight*
  • Case-Control Studies
  • Female
  • Fetal Development
  • Growth Hormone / blood*
  • Humans
  • Infant, Low Birth Weight / blood
  • Infant, Newborn
  • Insulin-Like Growth Factor Binding Protein 1 / blood
  • Insulin-Like Growth Factor I / metabolism
  • Placental Hormones / blood*
  • Pregnancy

Substances

  • GH2 protein, human
  • IGFBP1 protein, human
  • Insulin-Like Growth Factor Binding Protein 1
  • Placental Hormones
  • Insulin-Like Growth Factor I
  • Growth Hormone